Conference abstract · 29 Nov 2017
Conference abstractPublished 17 Aug 2015
Acid stable Alginate micro capsules for the improvement of solubility and gastrointestinal stability of Artemether and Lumefantrine
University of Nigeria, Nigeria.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Class II BCS drugs have dissolution and bioavailability challenges. Thus, lipid-based formulations have been explored to address them. Artemether and Lumefantrine investigated in this work are poorly soluble, requiring oral co-administration with oily foods to improve absorption. Oil or surfactant dispersions of these drugs may be prone to crystallization and acid hydrolysis (artemether) in the stomach. To prevent these unwanted events we encapsulated oil-surfactant solution of the drugs using an acid-stable wall-forming polymer. Considering the number of independent variables involved in the formulations, Full Factorial experimental design was employed to optimize their compositions. Therefore, the aims of the present study were to optimize excipient compositions and encapsulate (oil–surfactant solution of artemether and lumefantrine respectively with improved aqueous solubility and in vivo activity) in an acid-stable wall-forming calcium alginate capsules. A 33 Full Factorial experimental design was employed to optimize the compositions of the independent variables. The optimized batches were evaluated for quantity of oil encapsulated, percentage capsule yield, mean capsule diameter, percent loading efficiency, swelling index, in vitro drug release and in vivo antimalarial studies. Results showed that Alginate concentration most significantly (P < 0.05) contributed to variations in the parameters evaluated. Swelling index was higher in alkaline than acid pH. Less than 25% drug release was witnessed in SGF while up to 99 % release took place in SIF (pH 7.2). The optimized batches exhibited higher antimalarial activity compared to the commercial or pure drug samples. DSC revealed absence of drug crystallization. In conclusion, improved aqueous solubility and antimalarial activity of artemether and lumefantrine in acid-protective capsule membranes were achieved.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 31 Aug 2021
Bioavailability Enhancement of Artemether and Lumefantrine by Improving Solubility and Dissolution Rate using Solid Dispersion Technique
Research article · 30 Apr 2020
Enhancing Solubility and Bioavailability of Artemether and Lumefantrine through a Self-nano Emulsifying Drug Delivery System
Conference abstract · 26 Oct 2013
A rapid stability-indicating, fused-core HPLC method for simultaneous determination of beta-artemether and lumefantrine in anti-malarial fixed dose combination products
Conference abstract · 23 Nov 2017
Floating gastroretentive drug delivery system of antacids nanoparticles using hard alginate capsules.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Nicholas C Obitte”
